Overview

Nebulized Dexmedetomidine Versus Neostigmine/Atropine in Postdural Puncture Headache

Status:
Completed
Trial end date:
2021-09-03
Target enrollment:
Participant gender:
Summary
In our study, we will compare a new route of nebulization for effectiveness between dexmedetomidine, neostigmine/atropine and saline placebo for females complained of postdural puncture headache (PDPH) after cesarean section.
Phase:
Phase 3
Details
Lead Sponsor:
Assiut University
Treatments:
Atropine
Dexmedetomidine
Neostigmine